Evidence of early abnormal airways’ inflammation in children with type 1 diabetes

M. Saad (Milano, Italy), E. Franceschi (Milano, Italy), S. Pini (Milano, Italy), G. Croce (Milano, Italy), L. Perotto (Milano, Italy), M. Rizzi (Milano, Italy), D. Radovanovic (Milano, Italy), P. Santus (Milano, Italy), D. Radovanovic (Milano (MI), Italy)

Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches

Congress or journal article abstractE-poster

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Saad (Milano, Italy), E. Franceschi (Milano, Italy), S. Pini (Milano, Italy), G. Croce (Milano, Italy), L. Perotto (Milano, Italy), M. Rizzi (Milano, Italy), D. Radovanovic (Milano, Italy), P. Santus (Milano, Italy), D. Radovanovic (Milano (MI), Italy). Evidence of early abnormal airways’ inflammation in children with type 1 diabetes. 3933

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung function in children with juvenile diabetes type 1
Source: Eur Respir J 2002; 20: Suppl. 38, 139s
Year: 2002

Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009


Study of the connection between COPD, bronchial asthma and diabetes mellitus types 1 and 2
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009

Expression of type 1 and type 2 cytokines in central airways of smokers with chronic bronchitis
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001

Airway gene expression identifies subtypes of Type 2 inflammation in severe asthma
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020


Insulin therapy increases airway responsiveness in type 2 diabetes patients
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008


Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus
Source: Eur Respir J 2005; 26: Suppl. 49, 582s
Year: 2005

Prevalence of atopy and respiratory symptoms in type 1 diabetes mellitus (T1DM) patients
Source: Annual Congress 2005 - Environmental factors, allergy and asthma
Year: 2005


Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


Are spirometry indices associated with microvascular complications in type 1 diabetes subjects?
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019

Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation
Source: Eur Respir J, 58 (2) 2003393; 10.1183/13993003.03393-2020
Year: 2021



Altered exercise capacity in children with type 1 diabetes
Source: Virtual Congress 2021 – Respiratory physiology and breathing during sleep in health and sickness
Year: 2021


Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018


Risk of development of diabetes mellitus in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 323s
Year: 2006

Dupilumab efficacy in patients with GINA-defined type 2 asthma: TRAVERSE
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021



Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008

Association between bronchial reactivity and diabetes type 2
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019

PP306 – Submicroscopic changes of type I alveolocytes in the early stages of experimental diabetes mellitus
Source: ERS Lung Science Conference 2021
Year: 2021

Association between type 2 diabetes and respiratory symptoms
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010